Literature DB >> 2413704

Heredopathia atactica polyneuritiformis: Refsum's disease.

F B Gibberd, J D Billimoria, J M Goldman, M E Clemens, R Evans, M N Whitelaw, S Retsas, R M Sherratt.   

Abstract

Seven patients with Heredopathia Atactica Polyneuritiformis are described. There were 3 groups of clinical characteristics: first, congenital abnormalities such as skeletal deformities, unrelated to phytanic acid levels; second, signs and symptoms such as retinitis pigmentosa which come on slowly and are not directly related to the plasma phytanic acid level; third, lesions such as the neuropathy, rash and cardiac arrhythmias which can change quickly and are linked to the plasma phytanic acid level. Exacerbations of the signs in the third group are precipitated by a low calorie intake and mobilisation of phytanic acid from the adipose tissue. Poor vision is due not only to retinitis but also to small pupils which fail to dilate in the dark. The use of plasma exchange is discussed. With good dietary supervision it is possible to produce a considerable clinical recovery for the neuropathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413704     DOI: 10.1111/j.1600-0404.1985.tb01541.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

1.  Can patients with Refsum's disease safely eat green vegetables?

Authors:  S W Coppack; R Evans; F B Gibberd; M E Clemens; J D Billimoria
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

2.  A case of Refsum disease with atypical clinical picture in family members.

Authors:  R Marano; P Soliveri; B Garavaglia; A Antonelli; F Girotti
Journal:  Ital J Neurol Sci       Date:  1989-08

3.  The significance of plasma phytanic acid levels in adults.

Authors:  T C Britton; F B Gibberd; M E Clemens; J D Billimoria; M C Sidey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

4.  Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).

Authors:  D Harari; F B Gibberd; J P Dick; M C Sidey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

5.  Long-term plasma exchange in a case of Refsum's disease.

Authors:  D Leppert; U Schanz; J Burger; J Gmür; N Blau; W Waespe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

6.  Transport of phytanic acid on lipoproteins in Refsum disease.

Authors:  A S Wierzbicki; A Sankaralingam; P J Lumb; T C Hardman; M C Sidey; F B Gibberd
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

7.  Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease.

Authors:  Mateus Grings; Anelise Miotti Tonin; Lisiane Aurélio Knebel; Angela Zanatta; Alana Pimentel Moura; Carlos Severo Dutra Filho; Moacir Wajner; Guilhian Leipnitz
Journal:  Mol Cell Biochem       Date:  2012-04-15       Impact factor: 3.396

8.  Cutaneous aspects of Refsum's disease.

Authors:  B C Ramsay; K Meeran; D Woodrow; M Judge; J J Cream; F Clifford Rose; F B Gibberd
Journal:  J R Soc Med       Date:  1991-09       Impact factor: 18.000

9.  A family with heredopathia atactica polyneuritiformis (Refsum's disease).

Authors:  T C Britton; F B Gibberd
Journal:  J R Soc Med       Date:  1988-10       Impact factor: 18.000

10.  Hypokalaemia in acute Refsum's disease.

Authors:  J P Dick; K Meeran; F B Gibberd; F C Rose
Journal:  J R Soc Med       Date:  1993-03       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.